Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 306.50
Bid: 309.00
Ask: 310.50
Change: -8.50 (-2.70%)
Spread: 1.50 (0.485%)
Open: 311.50
High: 312.50
Low: 302.00
Prev. Close: 315.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SMALL-CAP WINNERS & LOSERS: DFS Furniture gains share of weak market

Thu, 21st Sep 2023 09:40

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Thursday.

----------

SMALL-CAP - WINNERS

----------

DFS Furniture PLC, up 4.9% 112.45p, 12-month range 101p-170p. The sofa retailer continues to win UK market share in a "very tough market" during its financial year, which ended on June 25, and outlines a path to improving margins. DFS says revenue from continuing operations fell 5.2% year-on-year to GBP1.09 billion from GBP1.15 billion, as pretax profit slumps 49% to GBP29.7 million from GBP58.5 million. Underlying profit before tax and brand amortisation is GBP30.6 million, which is in line with its interim guidance. DFS expects underlying profit before tax and brand amortisation to improve by a low single-digit percentage in financial 2024 to a GBP30 million to GBP35 million range. This assumes market volumes fall 5%, DFS notes. "We are confident the market will recover; however we can't predict how quickly that will happen. We have a clear route to a 5% [profit before tax] margin without market recovery, supported by further margin improvement, new cost efficiencies, and continued growth in Home," DFS says.

----------

Oxford BioMedica PLC, up 5.4% at 283.50 pence, 12-month range 236.50-575.00p. The cell and gene therapy company adds to Wednesday's gains after it announced exclusive talks with Institut Meriueux SA about buying ABL Europe, a pure-play European contract development and manufacturing organization. As part of the deal, Institut Merieux would become one of its major shareholders. The stock is down 16% over the past month however.

----------

SMALL-CAP - LOSERS

----------

James Fisher & Sons PLC, down 2.5% at 345.14p, 12-month range 241p-427.5p. The marine services swings to a pretax loss in the first half of 2023 of GBP4.4 million from a profit of GBP5.2 million a year before. This comes despite revenue rising 17% GBP252.0 million from GBP215.0 million. The loss is due to GBP9.3 million in refinancing legal and advisory costs, as well as higher interest rates, offsetting a positive operating performance, James Fisher explains. "All three divisions delivered revenue and profit growth against the first half of 2022, with a particularly strong increase seen in the Energy division," says CEO Jean Vernet. Trading in July and August is in line with its expectations, and James Fisher leaves its full-year expectations unchanged.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Apr 2016 12:54

DIRECTOR DEALINGS: Oxford Biomedica Executive Director Buys Shares

Read more
28 Apr 2016 08:37

Oxford Biomedica Loss Widens As Research Spending And Staff Grow

Read more
25 Apr 2016 08:29

DIRECTOR DEALINGS: Oxford BioMedica Chairman Ups Interest

Read more
21 Apr 2016 15:05

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Apr 2016 06:39

IXICO Enters Parkinson's Consortium And Secures Oxford Biomedica Deal

Read more
24 Mar 2016 11:14

DIRECTOR DEALINGS: Oxford Biomedica Chairman Ups Interest

Read more
7 Mar 2016 09:25

Oxford BioMedica Expands Collaboration, Inks Deal With Immune Design

Read more
25 Feb 2016 18:03

DIRECTOR DEALINGS: Oxford BioMedica Chairman Buys First Shares

Read more
23 Feb 2016 12:23

Oxford Biomedica to raise £8.1m in placing

(ShareCast News) - Biopharmaceutical company Oxford Biomedica plans to raise £8.1m in a placing of 128.4m shares at 6.3p with new and existing investors. The placing, which is priced at a 10% discount to the 7p closing price on 22 February, is to provide adequate working capital for the group to con

Read more
23 Feb 2016 08:26

Oxford BioMedica To Raise GBP8.1 Million In Discounted Placing (ALLISS)

Read more
29 Jan 2016 08:09

Oxford Biomedica Starts New Programme Under Novartis Deal

Read more
13 Jan 2016 08:43

Oxford Biomedica Gets UK Bulk Drug Manufacturing Approvals

Read more
15 Dec 2015 08:57

Oxford Biomedica Names Lorenzo Tallarigo As New Chairman

Read more
4 Nov 2015 10:42

Oxford BioMedica Making Progress On Strategy And Clinical Trials

Read more
28 Oct 2015 08:49

Oxford Biomedica Says Glaxo Exercises LentiVector Platform Option

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.